Meta-analysis: efficacy and safety of combination therapy of infliximab and immunosuppressives for Crohn's disease.

@article{Lin2011MetaanalysisEA,
  title={Meta-analysis: efficacy and safety of combination therapy of infliximab and immunosuppressives for Crohn's disease.},
  author={Ziwei Lin and Yu Bai and Ping Zheng},
  journal={European journal of gastroenterology & hepatology},
  year={2011},
  volume={23 12},
  pages={1100-10}
}
Although infliximab and immunosuppressives have both proved to be effective in the treatment of Crohn's disease (CD), the efficacy and safety of the combination therapy remained undetermined yet. We performed a meta-analysis to evaluate the efficacy and safety of combination therapy of infliximab and immunosuppressives compared with monotherapy for maintaining steroid-free clinical remission on patients with CD. We searched PubMed, Cochrane Library, and EMBASE. The primary end point was steroid… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 21 extracted citations

The benefit-to-risk balance of combining infliximab with azathioprine varies with age: a markov model.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association • 2015
View 4 Excerpts
Highly Influenced

Combination therapy for the treatment of Crohn's disease.

Expert opinion on biological therapy • 2015
View 1 Excerpt

Similar Papers

Loading similar papers…